Pancreatic Cancer Research

ResearcherBeckman Research InstituteActive in the last 2 years

Sang‐In Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3961-6083; OpenAlex author ID A5101827404. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. CF33-hNIS-antiPDL1 enhances immunogenicity and anti-tumor efficacy in an orthotopic syngeneic pancreatic cancer mouse model. Co-author DOI 10.1016/j.biopha.2025.118408↗
  2. Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for Treatment of Pancreatic Cancer: Toward a Universal Chimeric Antigen Receptor T-Cell … Co-author DOI 10.1097/xcs.0000000000000964↗
  3. PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-a… Co-author DOI 10.1016/j.omto.2021.12.022↗
  4. Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer. Co-author DOI 10.1016/j.omto.2022.02.022↗
  5. CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy. Co-author DOI 10.1038/s41417-021-00350-4↗
  6. Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer. Co-author DOI 10.1016/j.jamcollsurg.2019.12.027↗
  7. Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose. Co-author DOI 10.1186/s12967-018-1483-x↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuman Fong MD · 7 shared papers, 2018–2025 · strength 1.07
  2. Yanghee Woo · 6 shared papers, 2018–2025 · strength 0.85
  3. Zhifang Zhang · 5 shared papers, 2020–2025 · strength 0.77
  4. Susanne Gray Warner · 5 shared papers, 2018–2022 · strength 0.61
  5. Courtney Chen · 2 shared papers, 2024–2025 · strength 0.47
  6. Daniel D. Von Hoff · 2 shared papers, 2020–2022 · strength 0.25
  7. Haiyong Han · 1 shared paper, 2022 · strength 0.14
  8. Nanhai G. Chen · 1 shared paper, 2018 · strength 0.08
  9. Michael P. O’Leary · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.